Sequence Browser (Q04695-1)

UniProt (Ref Seq)
Displayed Structure
Experimental Tertiary/Complex (PDB:XRay/EM)
Experimental Tertiary/Complex (PDB:NMR)
Modelled Tertiary (Phyre)
If the whole structure is coloured grey in '3D Structure Viewer' panel, please click the icon - on the top left corner of the viewer.
(If nothing changes then 'Sequence ↔ Structure' mapping may be unavailable).
1
432
Isoform
Remark
Ref
Q04695-1  
Click on Isoform of interest to be redirected to the corresponding page
Type
Variation
Position
sequence conflict
Missing
94 - 108
sequence variant
M → T
88
sequence variant
Missing
92 - 99
sequence variant
N → H
92
sequence variant
Missing
94 - 98
sequence variant
R → H
94
sequence variant
L → P
95
sequence variant
Missing
97
sequence variant
L → P
99
sequence variant
N → D
109
sequence variant
L → R
388
mutagenesis site
E → A
106
mutagenesis site
N → A
154
mutagenesis site
L → A
157
mutagenesis site
N → A
333
sequence variant
M → K
88
sequence variant
L → P
91
sequence variant
N → D
92
sequence variant
N → S
92
sequence variant
R → C
94
sequence variant
R → P
94
sequence variant
L → Q
95
sequence variant
Y → D
98
sequence variant
V → M
102
sequence variant
L → P
388
mutagenesis site
R → A
103
mutagenesis site
N → A
109
mutagenesis site
I → A
155
mutagenesis site
D → A
160
mutagenesis site
R → A
334
mutagenesis site
L → A
339
sequence conflict
L → P
42
sequence conflict
T → A
51
sequence conflict
FG → SFE
73 - 74
sequence conflict
A → V
81
sequence conflict
T → I
137
sequence conflict
Q → H
158
sequence conflict
R → H
163
sequence conflict
R → C
180
sequence conflict
L → P
204
sequence conflict
Missing
225
sequence conflict
D → G
242
sequence conflict
R → C
305
sequence conflict
Q → R
352
sequence conflict
VKT → MKM
373 - 375
sequence conflict
A → T
382
mutagenesis site
C → A
336
sequence conflict
R → Q
30
sequence conflict
Missing
51 - 56
sequence conflict
S → SS
72
sequence conflict
G → E
74
sequence conflict
ILT → VGPA
145 - 147
sequence conflict
I → N
159
sequence conflict
D → A
167
sequence conflict
LR → PC
190 - 191
sequence conflict
Q → H
207
sequence conflict
L → P
229
sequence conflict
D → E
258
sequence conflict
V → M
337
sequence conflict
R → L
357
sequence conflict
Q → L
379
sequence conflict
R → H
385
sequence conflict
R → C
406
sequence conflict
H → R
428
sequence conflict
LTQYKKEPVT → FRMSESSPVS
395 - 404
sequence conflict
R → P
409

To analyse the structural impact of your missense variant:

  • Select the corresponding experimental/modelled structure from the "Available Structures" Panel.
  • Right-click on the target structure and download it.
  • Go to our web server Missense3D to analyse structural impact.

  • Go to Missense3D
Protein:
Other Names:
39.1, Cytokeratin-17, Keratin-17
Primary Accession:
Other Accessions:
A5Z1M9, A5Z1N0, A5Z1N1, A5Z1N2, A6NDV6, A6NKQ2, Q6IP98, Q8N1P6
Gene :
KRT17*
Organism :
Human
Entry Name :
Length :
432
Mass (Da) :
48,106
Last modified :
23-Jan-2007
Version :
v2
Isoforms :
1 
Variants :
66 
Interactions :
2 
Structures :
Experimental 0 | Phyre prediction 6

Type I keratin involved in the formation and maintenance of various skin appendages, specifically in determining shape and orientation of hair (By similarity). Required for the correct growth of hair follicles, in particular for the persistence of the anagen (growth) state (By similarity). Modulates the function of TNF-alpha in the specific context of hair cycling. Regulates protein synthesis and epithelial cell growth through binding to the adapter protein SFN and by stimulating Akt/mTOR pathway (By similarity). Involved in tissue repair. May be a marker of basal cell differentiation in complex epithelia and therefore indicative of a certain type of epithelial "stem cells". Acts as a promoter of epithelial proliferation by acting a regulator of immune response in skin: promotes Th1/Th17-dominated immune environment contributing to the development of basaloid skin tumors (By similarity). May act as an autoantigen in the immunopathogenesis of psoriasis, with certain peptide regions being a major target for autoreactive T-cells and hence causing their proliferation.

With
Entry
IntAct
Exp
CCDC85B
Q15834
EBI-297873, EBI-739674
2
EEF1G
P26641
EBI-297873, EBI-351467
2